Physician

Spyridon T Akrivakis, M.D.

According to 2025 Medicare claims, Spyridon Akrivakis, M.D. (NPI: 1508047481) practices cardiac electrophysiology in the Bangor, ME market, with the plurality of this provider's patient population coming from Penobscot, ME. This provider's primary affiliated billing organization is EASTERN MAINE MEDICAL CENTER (NPI: 1790789147; TIN: 010211501) and primary practice location at 04401-6616. Akrivakis is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Community Care Partnership of Maine, LLC (ACO ID: A2831), and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Akrivakis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 846 traditional Medicare patients, billed 1,506 HCPCS/CPT codes, and received $112,941 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 758 prescription claims across 245 beneficiaries totaling $182,994 in drug costs, led by Multaq (Dronedarone Hcl). 2018 DME data shows 15 claims. Open Payments data shows 9 records totaling $4,738. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $194,659 to $112,941. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $154,958 and ending at $182,994. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,148	2,293	$194,659
2016	1,173	2,211	$178,850
2017	1,070	2,162	$183,355
2018	864	1,829	$186,391
2019	1,098	2,143	$185,412
2020	981	1,748	$149,580
2021	862	1,709	$134,522
2022	742	1,463	$102,914
2023	768	1,314	$81,311
2024	846	1,506	$112,941

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	144	926	$154,958
2016	154	991	$195,443
2017	181	1,067	$169,677
2018	183	746	$148,088
2019	162	485	$114,760
2020	192	581	$106,057
2021	216	665	$122,374
2022	204	593	$133,028
2023	240	733	$190,186
2024	245	758	$182,994

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	15	$27,221
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	35	35	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	66	71	$58
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	75	80	$49
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	185	219	$24
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	445	548	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Multaq	Dronedarone Hcl	31	2,105	$54,829
Eliquis	Apixaban	25	2,025	$38,513
Jardiance	Empagliflozin	21	1,325	$25,175
Dofetilide	Dofetilide	91	6,068	$20,555
Entresto	Sacubitril/Valsartan	12	695	$15,475

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$388	BIOTRONIK INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$4,350	Elutia, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Spyridon T. Akrivakis, M.D.?

Tedicare shows public-source Medicare data for Spyridon T. Akrivakis, M.D. (NPI 1508047481), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Spyridon T. Akrivakis, M.D. have ACO affiliation data?

Spyridon T. Akrivakis, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831), and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Spyridon T. Akrivakis, M.D.?

Spyridon T. Akrivakis, M.D. is linked to EASTERN MAINE MEDICAL CENTER (billing NPI 1790789147) in the available physician profile data.

Does Spyridon T. Akrivakis, M.D. have Open Payments data?

Spyridon T. Akrivakis, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.